MEF-2 Polyclonal Antibody

Myocyte enhancer factor 2A encoded by MEF2A is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. Myocyte enhancer factor 2A can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in MEF2A could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for MEF2A.

The MEF-2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of myocyte enhancer factor 2 (MEF-2) protein. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards MEF-2.

MEF-2 is a transcription factor that plays a crucial role in the regulation of gene expression during myogenesis and neurogenesis. It is involved in the differentiation and development of various cell types, including skeletal and cardiac muscle cells, as well as neurons.

The MEF-2 Polyclonal Antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits excellent sensitivity and specificity, enabling accurate and reliable detection of MEF-2 protein in various sample types.

This antibody is supplied as a liquid formulation, allowing for easy handling and convenient storage. It is provided in a ready-to-use format, eliminating the need for additional reagents or preparation steps.

With its exceptional performance and reliability, the MEF-2 Polyclonal Antibody is an indispensable tool for researchers studying the role of MEF-2 in cellular processes and diseases. Its high specificity and sensitivity make it an ideal choice for investigating MEF-2 expression and function in various biological systems.